Literature DB >> 19390330

Combined antiretroviral treatment initiation during hospitalization: outcomes in South African adults.

Ingrid Eshun-Wilson, Helen Van der Plas, Hans W Prozesky, Michele D Zeier, Jean Nachega, Jantjie J Taljaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19390330      PMCID： PMC3070386          DOI： 10.1097/QAI.0b013e3181963cd4

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  Initial hospitalization and adherence to highly active antiretroviral therapy.

Authors:  Emanuela Lattuada; Massimiliano Lanzafame; Martina Gottardi; Fabiana Corsini; Ercole Concia; Sandro Vento
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

Review 2.  When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa?

Authors:  Stephen D Lawn; Robin Wood
Journal:  S Afr Med J       Date:  2007-06

Review 3.  Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease.

Authors:  Alessandro Soria; Adriano Lazzarin
Journal:  J Acquir Immune Defic Syndr       Date:  2007-09       Impact factor: 3.731

4.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Authors:  Martin W G Brinkhof; François Dabis; Landon Myer; David R Bangsberg; Andrew Boulle; Denis Nash; Mauro Schechter; Christian Laurent; Olivia Keiser; Margaret May; Eduardo Sprinz; Matthias Egger; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2008-07       Impact factor: 9.408
  4 in total
  4 in total

1.  Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis.

Authors:  H Sunpath; C Edwin; N Chelin; S Nadesan; R Maharaj; Y Moosa; L Smeaton; R Court; S Knight; E Gwyther; R A Murphy
Journal:  Int J Tuberc Lung Dis       Date:  2012-07       Impact factor: 2.373

2.  Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.

Authors:  Manuel Koller; Geoffrey Fatti; Benjamin H Chi; Olivia Keiser; Christopher J Hoffmann; Robin Wood; Hans Prozesky; Kathryn Stinson; Janet Giddy; Portia Mutevedzi; Matthew P Fox; Matthew Law; Andrew Boulle; Matthias Egger
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

3.  Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Authors:  Julia Bohlius; Fabio Valeri; Mhairi Maskew; Hans Prozesky; Daniela Garone; Mazvita Sengayi; Matthew P Fox; Mary-Ann Davies; Matthias Egger
Journal:  Int J Cancer       Date:  2014-05-02       Impact factor: 7.396

4.  Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients.

Authors:  Stefania Paolucci; Loretta Fiorina; Antonio Piralla; Roberto Gulminetti; Stefano Novati; Giorgio Barbarini; Paolo Sacchi; Marta Gatti; Luca Dossena; Fausto Baldanti
Journal:  Virol J       Date:  2012-10-24       Impact factor: 4.099
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.